168 related articles for article (PubMed ID: 28875010)
1. Anti-Apoptotic Effects of Osteopontin via the Up-Regulation of AKT/mTOR/β-Catenin Loop in Acute Myeloid Leukemia Cells.
Zahed Panah M; Nikbakht M; Sajjadi SM; Rostami S; Norooznezhad AH; Kamranzadeh Fumani H; Ghavamzadeh A; Mohammadi S
Int J Hematol Oncol Stem Cell Res; 2017 Apr; 11(2):148-157. PubMed ID: 28875010
[No Abstract] [Full Text] [Related]
2. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Veto the Effects of Osteopontin (OPN) Specific Inhibitor on Leukemic Stem Cell Colony Forming Potential via Promotion of OPN Overexpression.
Mohammadi S; Ghaffari SH; Shaiegan M; Nikogoftar Zarif M; Nikbakht M; Alimoghaddam K; Ghavamzadeh A
Int J Hematol Oncol Stem Cell Res; 2016 Jul; 10(3):120-9. PubMed ID: 27489587
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin plays a unique role in resistance of CD34+/CD123+ human leukemia cell lines KG1a to parthenolide.
Mohammadi S; Zahedpanah M; Ghaffari SH; Shaiegan M; Nikbakht M; Nikugoftar M
Life Sci; 2017 Nov; 189():89-95. PubMed ID: 28935249
[TBL] [Abstract][Full Text] [Related]
5. OPN b and c Isoforms Doubtless Veto Anti-angiogenesis Effects of Curcumin in Combination with Conventional AML Regiment.
Mirzaei A; Ghaffari SH; Nikbakht M; Kamranzadeh Foumani H; Vaezi M; Mohammadi S; Alimoghaddam K; Ghavamzadeh A
Asian Pac J Cancer Prev; 2017 Sep; 18(9):2591-2599. PubMed ID: 28952709
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal Interactions of Leukemic Cells with Bone Marrow Stromal Cells Promote Enrichment of Leukemic Stem Cell Compartments in Response to Curcumin and Daunorubicin.
Mohammadi S; Nikbakht M; Sajjadi SM; Rad F; Chahardouli B; Sabour Takanlu J; Rostami Sh; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
Asian Pac J Cancer Prev; 2017 Mar; 18(3):831-840. PubMed ID: 28441794
[TBL] [Abstract][Full Text] [Related]
7. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
[TBL] [Abstract][Full Text] [Related]
8. Parthenolide reduces gene transcription of prosurvival mediators in U937 cells.
Mohammadi S; Zahedpanah M; Nikbakht M; Shaiegan M; Hamidollah G; Nikugoftar M; Rahmani B; Hamedi Asl D
Exp Oncol; 2017 Mar; 39(1):30-35. PubMed ID: 28361855
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin b and c isoforms: Molecular Candidates Associated with Leukemic Stem Cell Chemoresistance in Acute Myeloid Leukemia.
Mirzaei A; Mohammadi S; Ghaffari SH; Nikbakht M; Bashash D; Alimoghaddam K; Ghavamzadeh A
Asian Pac J Cancer Prev; 2017 Jun; 18(6):1707-1715. PubMed ID: 28670893
[TBL] [Abstract][Full Text] [Related]
10. Novel Curcumin Liposome Modified with Hyaluronan Targeting CD44 Plays an Anti-Leukemic Role in Acute Myeloid Leukemia in Vitro and in Vivo.
Sun D; Zhou JK; Zhao L; Zheng ZY; Li J; Pu W; Liu S; Liu XS; Liu SJ; Zheng Y; Zhao Y; Peng Y
ACS Appl Mater Interfaces; 2017 May; 9(20):16857-16868. PubMed ID: 28489348
[TBL] [Abstract][Full Text] [Related]
11. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells.
Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B
Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745
[TBL] [Abstract][Full Text] [Related]
12. Parthenolide Induces Apoptosis in Committed Progenitor AML Cell line U937 via Reduction in Osteopontin.
Zahedpanah M; Shaiegan M; Ghaffari SH; Nikbakht M; Nikugoftar M; Mohammadi S
Rep Biochem Mol Biol; 2016 Apr; 4(2):82-8. PubMed ID: 27536701
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin is required for the maintenance of leukemia stem cells in acute myeloid leukemia.
Zhou J; Chen X; Zhou P; Sun X; Chen Y; Li M; Chu Y; Zhou J; Hu X; Luo Y; Yuan W; Wang G
Biochem Biophys Res Commun; 2022 Apr; 600():29-34. PubMed ID: 35182972
[TBL] [Abstract][Full Text] [Related]
14. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.
Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M
Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Enhanced Busulfan-Induced Apoptosis through Downregulating the Expression of Survivin in Leukemia Stem-Like KG1a Cells.
Weng G; Zeng Y; Huang J; Fan J; Guo K
Biomed Res Int; 2015; 2015():630397. PubMed ID: 26557682
[TBL] [Abstract][Full Text] [Related]
16. A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase.
Zhou J; Toh SH; Chan ZL; Quah JY; Chooi JY; Tan TZ; Chong PSY; Zeng Q; Chng WJ
J Hematol Oncol; 2018 Mar; 11(1):36. PubMed ID: 29514683
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients.
Liersch R; Gerss J; Schliemann C; Bayer M; Schwöppe C; Biermann C; Appelmann I; Kessler T; Löwenberg B; Büchner T; Hiddemann W; Müller-Tidow C; Berdel WE; Mesters R
Blood; 2012 May; 119(22):5215-20. PubMed ID: 22510874
[TBL] [Abstract][Full Text] [Related]
18. PI-103 sensitizes acute myeloid leukemia stem cells to daunorubicin-induced cytotoxicity.
Ding Q; Gu R; Liang J; Zhang X; Chen Y
Med Oncol; 2013 Mar; 30(1):395. PubMed ID: 23335068
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
Tabe Y; Tafuri A; Sekihara K; Yang H; Konopleva M
Expert Opin Ther Targets; 2017 Jul; 21(7):705-714. PubMed ID: 28537457
[TBL] [Abstract][Full Text] [Related]
20. Fas receptor-Fas ligand system is independent of both CD34 status and chemosensitivity in acute myeloid leukemia.
Lewis NR; Pallis M; Russell NH
Exp Hematol; 2000 May; 28(5):535-42. PubMed ID: 10812243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]